Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study | Zendy

Jason A. Roberts | Zendy; Robert Boots | Zendy; Claire M. Rickard | Zendy; P. Thomas | Zendy; Jennifer A. Quinn | Zendy; Darren M. Roberts | Zendy; Brent Richards | Zendy; Jeffrey Lipman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Is continuous infusion ceftriaxone better than once-a-day dosing in intensive care? A randomized controlled pilot study

Author(s) -

Jason A. Roberts,

Robert Boots,

Claire M. Rickard,

P. Thomas,

Jennifer A. Quinn,

Darren M. Roberts,

Brent Richards,

Jeffrey Lipman

Publication year - 2006

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkl478

Subject(s) - medicine , ceftriaxone , bolus (digestion) , dosing , odds ratio , confidence interval , randomized controlled trial , intensive care unit , sepsis , intensive care , anesthesia , surgery , antibiotics , intensive care medicine , microbiology and biotechnology , biology

To compare the clinical and bacteriological outcome of critically ill patients with sepsis treated by ceftriaxone administered as a once-a-day intermittent bolus dose or by 24 h continuous infusion.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research